AstraZeneca suspends Covid vaccine trials after ‘unexplained’ illness
The drugmaker has voluntarily paused trials to allow an independent committee to review safety data after a study participant fell ill
09 September 2020 - 08:20
San Francisco/Tokyo/Seoul/Singapore — AstraZeneca said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.
The vaccine, developed with the University of Oxford, has been described by the World Health Organisation (WHO) as probably the world’s leading candidate and the most advanced in terms of development. The suspension dims prospects for an early rollout amid reports that the US was aiming for a fast-track approval before the November presidential election...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.